-
Core products are embroiled in lawsuits, products under development are difficult to fulfill, and BeiGene is approaching the brink of delisting
BeiGene (688235. SH) is a well-known innovative pharmaceutical company in the A-share market. From 2017 to the first half of 2024, the company's R&D investment in all phases was the highest among A-s ... -
Zhihu launches a new AI product called "Zhihu Direct Answer"
At the 10th Salt Club New Knowledge Youth Conference held recently, Zhihu launched its latest AI product "Zhihu Direct Answer". Through innovative big model applications, it brings new productivity t ... -
Zhihu launches a new AI product called "Zhihu Direct Answer"
On June 29th, at the new Salt Club New Knowledge Youth Conference, Zhou Yuan, founder, chairman, and CEO of Zhihu, released Zhihu's latest AI product "Zhihu Direct Answer". "Zhihu Direct Answer" is t ...